Tempus announced its acquisition of Ambry Genetics for $375 million in cash and $225 million in shares at closing in November and the deal closed earlier this month. Ambry will continue to operate ...

CHICAGO, February 03, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has ...

Shares of Tempus AI TEM gained 18.4% after it announced an agreement, on Nov. 4, 2024, to acquire Ambry Genetics for $600 million. This acquisition will likely help Tempus revolutionize healthcare ...

Aliso Viejo-based Ambry Genetics Corp. on Nov. 4 announced an agreement to be acquired for $600 million by Tempus AI Inc. “They’ve achieved one of the rare things in our space where you actually have ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Tempus AI announced today it is acquiring genetic ...

Ambry Genetics, a leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., today announced the ExomeReveal™ test, a new multiomic exome sequencing test designed to improve rare ...

Ambry Thomas fractured his forearm during San ... Cohn live streams almost every day and posts videos hourly during the football season. Cohn is committed to asking the questions that 49ers ...

UCI officials plan to rename the school the Charlie Dunlop School of Biological Sciences. Dunlop founded Ambry Genetics in 1999, and led the Aliso Viejo, Calif., genetic testing company until he sold ...

Ambry Genetics, along with PacBio (NASDAQ: PACB), announced their companies’ selection by the University of California, Irvine (UCI) and the GREGoR Consortium (Genomics Research to Elucidate the ...